SCHEMBL30069765

SCHEMBL30069765

CC1(C)OC(=O)C(=C(O)Cc2cccc3ccccc23)C(=O)O1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.51
PTPN1 P18031 4/20 0.42
ACP1 P24666 2/20 0.42
CDC25B P30305 2/20 0.42
ATM Q13315 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
PTGER4 P35408 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
POLB P06746 1/20 0.40
ACP3 P15309 1/20 0.40
SIRT5 Q9NXA8 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17761135 1.00 TDP1 (0.51) TDP1PTPN1ACP1CDC25BATM
SCHEMBL25253304 0.79 PTPN1 (0.44) PTPN1ACP1CDC25BKMT2AMAPT
SCHEMBL19456965 0.79 TDP1 (0.44) TDP1ATML3MBTL1MEN1KMT2A
SCHEMBL17760903 0.78 PTPN1 (0.43) PTPN1ACP1CDC25BHTTCYP1A2
SCHEMBL319410 0.77 PTPN1 (0.50) PTPN1ACP1CDC25BL3MBTL1KMT2A
SCHEMBL30069860 0.72 PTPN1 (0.36) PTPN1ACP1CDC25BMEN1KMT2A
SCHEMBL6078340 0.72 CYP1A2 (0.43) TDP1ATML3MBTL1MEN1KMT2A
SCHEMBL6078346 0.72 CYP1A2 (0.43) TDP1ATML3MBTL1MEN1KMT2A
SCHEMBL22409623 0.71 NQO2 (0.41) TDP1MEN1KMT2AMAPTLMNA
SCHEMBL30167913 0.71 PTPN1 (0.44) PTPN1ACP1CDC25BSMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230131899-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID AXIAL THERAPEUTICS, INC. (US) 2023-04-27 US disclosed
EP-4087560-A2 INHIBITORS OF MICROBIALLY INDUCED AMYLOID Axial Therapeutics, Inc. (US) 2022-11-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230131899-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID SNCA, PARK7, PRNP TDP1 452/4885PTPN1 2068/4885ACP1 1713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.